Radiotherapy–immunotherapy combinations – perspectives and challenges-Reference-Cited by-同舟云学术

Radiotherapy–immunotherapy combinations – perspectives and challenges

Published:2020-03-13 Issue:7 Volume:14 Page:1529-1537
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Mondini Michele¹²^ORCID,Levy Antonin²³,Meziani Lydia¹²,Milliat Fabien⁴,Deutsch Eric¹²³

Affiliation:

1. Gustave Roussy Université Paris‐Saclay SIRIC SOCRATE Villejuif France

2. INSERM U1030 Labex LERMIT Villejuif France

3. Département de Radiothérapie Gustave Roussy Université Paris‐Saclay DHU TORINO Villejuif France

4. Department of Radiobiology and regenerative Medicine (SERAMED) Laboratory of Medical Radiobiology (LRMed) Institute for Radiological Protection and Nuclear Safety (IRSN) Fontenay‐aux‐Roses France

Funder

Fondation ARC pour la Recherche sur le Cancer

Agence Nationale de la Recherche

Institut National Du Cancer

Institut National de la Santé et de la Recherche Médicale

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12658

Reference45 articles.

1. Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

2. Tumor-reprogrammed resident T cells resist radiation to control tumors

3. Repurposing DNA repair factors to eradicate tumor cells upon radiotherapy

4. Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences

5. Time to abandon single-site irradiation for inducing abscopal effects

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current immunotherapy techniques in meningioma;Expert Review of Anticancer Therapy;2024-09-04

2. Ionizing radiation altered the expression profiles and intracellular distribution of the circadian gene per1 in mouse brain neuronal cells;2024-08-09

3. Is Local Ablative Stereotactic Radiation Therapy a Valuable Rescue Strategy for Time on Drug in Patients Enrolled in Phase I Trials?;International Journal of Radiation Oncology*Biology*Physics;2024-08

4. Combination of Radiation Therapy, Wim’s Tumor 1 (WT1) Dendritic Cell Vaccine Therapy, and α-Galactosylceramide-Pulsed Dendritic Cell Vaccine Therapy for End-Stage Small Bowel Cancer;Cureus;2024-07-20

5. Thrombocytopenia and hyperprogression after radiotherapy and camrelizumab treatment in an esophageal cancer patient with increased JAK2 gene copies: a case report;Frontiers in Oncology;2024-06-21